CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc.

1:16-cv-11091

Overview

Case Number 1:16-cv-11091
Filing Date 2016-06-10
Status Terminated
Termination Date 2016-10-06
Court District Court, D. Massachusetts (mad)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 15:1126 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Collegium Pharmaceutical, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Purdue Pharma, L.P. NPE (University / Research)

Represented By

1 Attorneys Listed

Christopher M. Morrison

Jones Day (Bos)

Tel: +1 (617) 960-3939
Fax: +1 (212) 755-7306

Jones Day (Bos), 100 High Street

Court & Judges

Court

District Court, D. Massachusetts (mad)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9155717
Pharmaceutical formulation containing irritant
Filed: 2014-01-07
Issued: 2015-10-13
Active (7.1 yrs remaining)
Expires: 2034-01-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

0

Motions by Category

Procedural / Extension Motion 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
Order on Motion for Leave to Appear
Entry #β€” • 2016-08-16

Docket Entries

(6 total)
Pleading / Complaint

COMPLAINT against Collegium Pharmaceutical, Inc. Filing fee: $ 400, receipt number 0101-6151526 (Fee Status: Filing Fee paid), filed by Purdue Pharma, L.P.. (Attachments: # 1 Exhibit A: US Patent No. 9,155,717, # 2 Civil Cover Sheet, # 3 Category Form)(Morrison, Christopher) (Modified on 6/10/2016 to Correct Docket Text and Filer) (Paine, Matthew). (Attachment 2 replaced on 6/10/2016) (Paine, Matthew). (Attachment 3 replaced on 6/10/2016) (Paine, Matthew). (Entered: 06/10/2016)

Entry #1 • 2016-06-10
1

REPORT ON THE FILING/TERMINATION OF AN ACTION REGARDING PATENT OR TRADEMARK. (Morrison, Christopher) (Main Document 2 replaced on 6/10/2016) (Paine, Matthew). (Entered: 06/10/2016)

Entry #2 • 2016-06-10
1

CORPORATE DISCLOSURE STATEMENT by Purdue Pharma, L.P. identifying Other Affiliate Purdue Holdings L.P. for Purdue Pharma, L.P... (Morrison, Christopher) (Entered: 06/10/2016)

Entry #3 • 2016-06-10
1

ELECTRONIC NOTICE of Case Assignment. Judge F. Dennis Saylor, IV assigned to case. (adminn, ) (Entered: 06/10/2016)

Entry #4 • 2016-06-10
1

Summons Issued as to Collegium Pharmaceutical, Inc.. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (adminn, ) (Entered: 06/10/2016)

Entry #5 • 2016-06-10
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc